Haeme oxygenase-1 overexpression via nAChRs and the transcription factor Nrf2 has antinociceptive effects in the formalin test

Pain

Volumn 146, Issue 1-2, 2009, Pages 75-83

  Egea, Javier ^a,b   Rosa, Angelo O ^a,b   Lorrio, Silvia ^a,b   del Barrio, Laura ^a,b   Cuadrado, Antonio ^a,c   López, Manuela G ^a,b  

^a INSTITUTO TEÓFILO HERNANDO   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Epibatidine; Haeme oxygenase 1; Inflammation; Pain

Indexed keywords

BETA ACTIN; BUNGAROTOXIN RECEPTOR; DIHYDRO BETA ERYTHROIDINE; EPIBATIDINE; FORMALDEHYDE; HEME OXYGENASE 1; MECAMYLAMINE; METHYLLYCACONITINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA9; PROTOPORPHYRIN; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; KNOCKOUT MOUSE; LEUKOCYTE; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; WESTERN BLOTTING;

ACETIC ACID; ANALGESICS; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; BLOTTING, WESTERN; ENZYME INDUCTION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; FORMALDEHYDE; HEME OXYGENASE-1; IMMUNOHISTOCHEMISTRY; MALE; MICE; NF-E2-RELATED FACTOR 2; NICOTINIC AGONISTS; PAIN MEASUREMENT; PROTOPORPHYRINS; PYRIDINES; RECEPTORS, NICOTINIC;

EID: 70349765539     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2009.07.007     Document Type: Article

References (53)

1. Alkondon M., Pereira E.F., Cortes W.S., Maelicke A., and Albuquerque E.X. Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons. Eur J Neurosci 9 (1997) 2734-2742
2. Bonhaus D.W., Bley K.R., Broka C.A., Fontana D.J., Leung E., Lewis R., Shieh A., and Wong E.H. Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine. J Pharmacol Exp Ther 272 (1995) 1199-1203
3. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., Wang H., Abumrad N., Eaton J.W., and Tracey K.J. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405 (2000) 458-462
4. Boyce S., Webb J.K., Shepheard S.L., Russell M.G., Hill R.G., and Rupniak N.M. Analgesic and toxic effects of ABT-594 resemble epibatidine and nicotine in rats. Pain 85 (2000) 443-450
5. Broide R.S., and Leslie F.M. The alpha7 nicotinic acetylcholine receptor in neuronal plasticity. Mol Neurobiol 20 (1999) 1-16
6. Curzon P., Nikkel A.L., Bannon A.W., Arneric S.P., and Decker M.W. Differences between the antinociceptive effects of the cholinergic channel activators A-85380 and (+/-)-epibatidine in rats. J Pharmacol Exp Ther 287 (1998) 847-853
7. Damaj M.I., Fei-Yin M., Dukat M., Glassco W., Glennon R.A., and Martin B.R. Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice. J Pharmacol Exp Ther 284 (1998) 1058-1065
8. de Jonge W.J., and Ulloa L. The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br J Pharmacol 151 (2007) 915-929
9. Egea J., Rosa A.O., Cuadrado A., Garcia A.G., and Lopez M.G. Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress. J Neurochem 102 (2007) 1842-1852
10. Fujii T., Tajima S., Yamada S., Watanabe Y., Sato K.Z., Matsui M., Misawa H., Kasahara T., and Kawashima K. Constitutive expression of mRNA for the same choline acetyltransferase as that in the nervous system, an acetylcholine-synthesizing enzyme, in human leukemic T-cell lines. Neurosci Lett 259 (1999) 71-74
11. Ghia J.E., Blennerhassett P., Kumar-Ondiveeran H., Verdu E.F., and Collins S.M. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 131 (2006) 1122-1130
12. Gilbert S.D., Clark T.M., and Flores C.M. Antihyperalgesic activity of epibatidine in the formalin model of facial pain. Pain 89 (2001) 159-165
13. Itoh K., Tong K.I., and Yamamoto M. Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med 36 (2004) 1208-1213
14. Kesingland A.C., Gentry C.T., Panesar M.S., Bowes M.A., Vernier J.M., Cube R., Walker K., and Urban L. Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain. Pain 86 (2000) 113-118
15. Khan I.M., Buerkle H., Taylor P., and Yaksh T.L. Nociceptive and antinociceptive responses to intrathecally administered nicotinic agonists. Neuropharmacology 37 (1998) 1515-1525
16. Kim Y.S., Zhuang H., Koehler R.C., and Dore S. Distinct protective mechanisms of HO-1 and HO-2 against hydroperoxide-induced cytotoxicity. Free Radic Biol Med 38 (2005) 85-92
17. Lawand N.B., Lu Y., and Westlund K.N. Nicotinic cholinergic receptors: potential targets for inflammatory pain relief. Pain 80 (1999) 291-299
18. Li X., and Clark J.D. The role of heme oxygenase in neuropathic and incisional pain. Anesth Analg 90 (2000) 677-682
19. Lloyd G.K., and Williams M. Neuronal nicotinic acetylcholine receptors as novel drug targets. J Pharmacol Exp Ther 292 (2000) 461-467
20. Marubio L.M., and Changeux J. Nicotinic acetylcholine receptor knockout mice as animal models for studying receptor function. Eur J Pharmacol 393 (2000) 113-121
21. Marubio L.M., del Mar Arroyo-Jimenez M., Cordero-Erausquin M., Lena C., Le Novere N., de Kerchove d'Exaerde A., Huchet M., Damaj M.I., and Changeux J.P. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 398 (1999) 805-810
22. Matsunaga K., Klein T.W., Friedman H., and Yamamoto Y. Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine. J Immunol 167 (2001) 6518-6524
23. Meyer M.D., Decker M.W., Rueter L.E., Anderson D.J., Dart M.J., Kim K.H., Sullivan J.P., and Williams M. The identification of novel structural compound classes exhibiting high affinity for neuronal nicotinic acetylcholine receptors and analgesic efficacy in preclinical models of pain. Eur J Pharmacol 393 (2000) 171-177
24. Michaelis M., Vogel C., Blenk K.H., Arnarson A., and Janig W. Inflammatory mediators sensitize acutely axotomized nerve fibers to mechanical stimulation in the rat. J Neurosci 18 (1998) 7581-7587
25. Nakahira K., Kim H.P., Geng X.H., Nakao A., Wang X., Murase N., Drain P.F., Wang X., Sasidhar M., Nabel E.G., Takahashi T., Lukacs N.W., Ryter S.W., Morita K., and Choi A.M. Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. J Exp Med 203 (2006) 2377-2389
26. Picciotto M.R., Caldarone B.J., King S.L., and Zachariou V. Nicotinic receptors in the brain. Links between molecular biology and behavior. Neuropsychopharmacology 22 (2000) 451-465
27. Poss K.D., and Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 94 (1997) 10925-10930
28. Rangasamy T., Guo J., Mitzner W.A., Roman J., Singh A., Fryer A.D., Yamamoto M., Kensler T.W., Tuder R.M., Georas S.N., and Biswal S. Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med 202 (2005) 47-59
29. Rashid M.H., and Ueda H. Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism. Brain Res 953 (2002) 53-62
30. Rosa A.O., Egea J., Lorrio S., Rojo A.I., Cuadrado A., and Lopez M.G. Nrf2-mediated haeme oxygenase-1 up-regulation induced by cobalt protoporphyrin has antinociceptive effects against inflammatory pain in the formalin test in mice. Pain 132 (2008) 332-339
31. Rosa K.A., Gadotti V.M., Rosa A.O., Rodrigues A.L., Calixto J.B., and Santos A.R. Evidence for the involvement of glutamatergic system in the antinociceptive effect of ascorbic acid. Neurosci Lett 381 (2005) 185-188
32. Santos A.R., Miguel O.G., Yunes R.A., and Calixto J.B. Antinociceptive properties of the new alkaloid, cis-8, 10-di-N-propyllobelidiol hydrochloride dihydrate isolated from Siphocampylus verticillatus: evidence for the mechanism of action. J Pharmacol Exp Ther 289 (1999) 417-426
33. 2+ channels via redox modulation of key cysteine residues by mitochondrial reactive oxygen species. J Biol Chem 283 (2008) 24412-24419
34. Schafers M., Brinkhoff J., Neukirchen S., Marziniak M., and Sommer C. Combined epineurial therapy with neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1 receptor has an additive effect in reducing neuropathic pain in mice. Neurosci Lett 310 (2001) 113-116
35. Shan Y., Lambrecht R.W., Donohue S.E., and Bonkovsky H.L. Role of Bach1 and Nrf2 in up-regulation of the heme oxygenase-1 gene by cobalt protoporphyrin. FASEB J 20 (2006) 2651-2653
36. Skok V.I. Nicotinic acetylcholine receptors in autonomic ganglia. Auton Neurosci 97 (2002) 1-11
37. Sommer C., Lindenlaub T., Teuteberg P., Schafers M., Hartung T., and Toyka K.V. Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy. Brain Res 913 (2001) 86-89
38. Sommer C., Petrausch S., Lindenlaub T., and Toyka K.V. Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy. Neurosci Lett 270 (1999) 25-28
39. Sorkin L.S., and Doom C.M. Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake rat. J Peripher Nerv Syst 5 (2000) 96-100
40. Sorkin L.S., Xiao W.H., Wagner R., and Myers R.R. Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 81 (1997) 255-262
41. Spande T.F., Garraffo H.M., Yeh H.J., Pu Q.L., Pannell L.K., and Daly J.W. A new class of alkaloids from a dendrobatid poison frog: a structure for alkaloid 251F. J Nat Prod 55 (1992) 707-722
42. Steiner A.A., Branco L.G., Cunha F.Q., and Ferreira S.H. Role of the haeme oxygenase/carbon monoxide pathway in mechanical nociceptor hypersensitivity. Br J Pharmacol 132 (2001) 1673-1682
43. Takahashi H.K., Iwagaki H., Hamano R., Yoshino T., Tanaka N., and Nishibori M. Effect of nicotine on IL-18-initiated immune response in human monocytes. J Leukoc Biol 80 (2006) 1388-1394
44. Thimmulappa R.K., Scollick C., Traore K., Yates M., Trush M.A., Liby K.T., Sporn M.B., Yamamoto M., Kensler T.W., and Biswal S. Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide. Biochem Biophys Res Commun 351 (2006) 883-889
45. Tracey K.J. The inflammatory reflex. Nature 420 (2002) 853-859
46. Ulloa L. The vagus nerve and the nicotinic anti-inflammatory pathway. Nat Rev Drug Discov 4 (2005) 673-684
47. van Westerloo D.J., Giebelen I.A., Florquin S., Bruno M.J., Larosa G.J., Ulloa L., Tracey K.J., and van der Poll T. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 130 (2006) 1822-1830
48. Verbitsky M., Rothlin C.V., Katz E., and Elgoyhen A.B. Mixed nicotinic-muscarinic properties of the alpha9 nicotinic cholinergic receptor. Neuropharmacology 39 (2000) 2515-2524
49. Vincler M., Wittenauer S., Parker R., Ellison M., Olivera B.M., and McIntosh J.M. Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors. Proc Natl Acad Sci USA 103 (2006) 17880-17884
50. Wagner R., and Myers R.R. Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. Neuroreport 7 (1996) 2897-2901
51. Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., Li J.H., Wang H., Yang H., Ulloa L., Al-Abed Y., Czura C.J., and Tracey K.J. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421 (2003) 384-388
52. Wang Y., Pereira E.F., Maus A.D., Ostlie N.S., Navaneetham D., Lei S., Albuquerque E.X., and Conti-Fine B.M. Human bronchial epithelial and endothelial cells express alpha7 nicotinic acetylcholine receptors. Mol Pharmacol 60 (2001) 1201-1209
53. Wang Y., Su D.M., Wang R.H., Liu Y., and Wang H. Antinociceptive effects of choline against acute and inflammatory pain. Neuroscience 132 (2005) 49-56